Andrea Biffi

TOKENANCE is a boutique consultancy + software house that turns emerging tech into real-world growth for forward-thinking brands and SMEs. Now backed by DigitCo GmbH (Zug, Switzerland), we design and build AI-, Web3-, and blockchain-powered platforms that put the forthcoming EU Digital Product Passport and circular-economy rules to work for you. Our main blockchain partners are the Cardano Foundation and Circular Protocol. What we do - Digital Product Passport suites—fast-track compliance while delighting customers with transparency and traceability. - Custom AI & Web3 solutions—from concept to cloud, tailored to enterprise, SME, and consumer-brand needs. - RE-Twin.com (with Cardano Foundation)—the first wallet-free, blockchain document hub and digital-twin SaaS for real estate pros, distributed via our joint venture with YurekAI. Why TOKENANCE - Original, customer-centric product design - End-to-end support, from advisory to full-stack delivery - Swiss precision, global vision Join us as we expand the TOKENANCE vision to new frontiers under DigitCo’s banner—bringing transparency, efficiency, and loyalty to every interaction, B2B, B2C, or B2B2C. Let’s connect and build the future together.

1MED is a full-service CRO and regulatory consultancy specialising in MedTech, biotech and pharmaceutical development. We provide end-to-end support including ISO 13485-compliant quality management, MDR/IVDR regulatory strategy, and clinical trials from first-in-human to post-market studies. Founded in 2014 and headquartered in Agno, Switzerland, 1MED employs 100+ professionals delivering global operational support. Our mission is to help MedTech innovators navigate the complexity of developing safe, effective medical devices in compliance with MDR and FDA regulations. Our expertise spans the entire product lifecycle—from research and preclinical testing to quality system implementation, regulatory submissions, clinical study management and post-market activities. This cross-functional approach has contributed to the certification or maintenance of more than 500 medical devices in recent years. We support clients ranging from start-ups to global leaders, across therapeutic areas including cardiovascular, orthopedic, ophthalmology, dental, dermatology, wound care, gastrointestinal, urology, surgical tools, drug delivery systems, IVDs and software/AI-based devices. In addition to in-house capabilities, 1MED maintains strong partnerships with preferred vendors, European Notified Bodies and Competent Authorities. Learn more at https://www.1med.net or contact info@1med.ch

Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.

TOKENANCE is a boutique consultancy + software house that turns emerging tech into real-world growth for forward-thinking brands and SMEs. Now backed by DigitCo GmbH (Zug, Switzerland), we design and build AI-, Web3-, and blockchain-powered platforms that put the forthcoming EU Digital Product Passport and circular-economy rules to work for you. Our main blockchain partners are the Cardano Foundation and Circular Protocol. What we do - Digital Product Passport suites—fast-track compliance while delighting customers with transparency and traceability. - Custom AI & Web3 solutions—from concept to cloud, tailored to enterprise, SME, and consumer-brand needs. - RE-Twin.com (with Cardano Foundation)—the first wallet-free, blockchain document hub and digital-twin SaaS for real estate pros, distributed via our joint venture with YurekAI. Why TOKENANCE - Original, customer-centric product design - End-to-end support, from advisory to full-stack delivery - Swiss precision, global vision Join us as we expand the TOKENANCE vision to new frontiers under DigitCo’s banner—bringing transparency, efficiency, and loyalty to every interaction, B2B, B2C, or B2B2C. Let’s connect and build the future together.

1MED is a full-service CRO and regulatory consultancy specialising in MedTech, biotech and pharmaceutical development. We provide end-to-end support including ISO 13485-compliant quality management, MDR/IVDR regulatory strategy, and clinical trials from first-in-human to post-market studies. Founded in 2014 and headquartered in Agno, Switzerland, 1MED employs 100+ professionals delivering global operational support. Our mission is to help MedTech innovators navigate the complexity of developing safe, effective medical devices in compliance with MDR and FDA regulations. Our expertise spans the entire product lifecycle—from research and preclinical testing to quality system implementation, regulatory submissions, clinical study management and post-market activities. This cross-functional approach has contributed to the certification or maintenance of more than 500 medical devices in recent years. We support clients ranging from start-ups to global leaders, across therapeutic areas including cardiovascular, orthopedic, ophthalmology, dental, dermatology, wound care, gastrointestinal, urology, surgical tools, drug delivery systems, IVDs and software/AI-based devices. In addition to in-house capabilities, 1MED maintains strong partnerships with preferred vendors, European Notified Bodies and Competent Authorities. Learn more at https://www.1med.net or contact info@1med.ch

Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.